Ausgabe 1/2014
Inhalt (30 Artikel)
TEG® and RapidTEG® are unreliable for detecting warfarin-coagulopathy: a prospective cohort study
C Michael Dunham, Charlene Rabel, Barbara M Hileman, Jason Schiraldi, Elisha A Chance, Mark T Shima, Alddo A Molinar, David A Hoffman
Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
Mauro Molteni, Claudio Cimminiello
Incidence of venous thromboembolism in northern Sweden (VEINS): a population-based study
Magdalena Johansson, Lars Johansson, Marcus Lind
Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs
Raul Altman, Claudio Daniel Gonzalez
The role of prothrombin complex concentrates in reversal of target specific anticoagulants
Katrina Babilonia, Toby Trujillo
Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel
Joseph F Dwyer, Jill A McCoy, Ziping Yang, Michael Husser, Heinz Redl, Mary Ann Murphy, Martin Wolfsegger, James P DiOrio, Andreas Goppelt, Shane Donovan
Management of pregnancy associated venous-thromboembolism: a survey of practices
Esteban Gándara, Marc Carrier, Marc A Rodger
Enhanced pre-operative thrombolytic status is associated with the incidence of deep venous thrombosis in patients undergoing total knee arthroplasty
Yukinori Tamura, Shigeshi Mori, Shigeki Asada, Naoyuki Kawao, Shigeru Ueshima, Hiroshi Kaji, Junichiro Yamamoto, Masao Akagi, Osamu Matsuo
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression
Elizabeth S Mearns, C Michael White, Christine G Kohn, Jessica Hawthorne, Ju-Sung Song, Joy Meng, Jeff R Schein, Monika K Raut, Craig I Coleman
Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in Argentina: a multicentric cross-sectional study
Fernando Vazquez, Ricardo Watman, Aldo Tabares, Carina Gumpel, Enrique Baldessari, Alicia B Vilaseca, Federico J Capparelli, Esteban Lifschitz
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis
Walter Ageno, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Verena Haupt, Jonas Schneider, Alexander GG Turpie
Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion
Işıl Kutluturk, Ali Karagöz, Tahir Bezgin, Vecih Oduncu, Ali Elveran, Cem Doğan, Ahmet Elbay, Cevat Kirma, Yusuf Özertürk
The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI
Gabriele Demetz, Magdalena Laux, Armin Scherhag, Tiny Hoekstra, Marit M Suttorp, Friedo Dekker, Mark Roest, Mira Marcus-Kalish, Moshe Mittelman, Ilka Ott
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
Gebrehiwot Teklay, Nuredin Shiferaw, Befikadu Legesse, Mebratu Legesse Bekele
Treatment options for venous thromboembolism: lessons learnt from clinical trials
Simon McRae
Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents
Tarek Owaidah, Nahlah AlGhasham, Saad AlGhamdi, Dania AlKhafaji, Bandar ALAmro, Mohamed Zeitouni, Fawaz Skaff, Hazzaa AlZahrani, Adher AlSayed, Naser ElKum, Mahmoud Moawad, Ahmed Nasmi, Mohannad Hawari, Khalid Maghrabi
Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden
Ashkan Labaf, Martin Carlwe, Peter J Svensson
Severe hyperhomocysteinemia due to cystathionine β-synthase deficiency, and Factor V Leiden mutation in a patient with recurrent venous thrombosis
Zuhier Awan, Sumayah Aljenedil, David S Rosenblatt, Jean Cusson, Brian M Gilfix, Jacques Genest
Hypothermia: effects on platelet function and hemostasis
Sven Van Poucke, Kris Stevens, Abraham Emanuel Marcus, Marcus Lancé
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism
Sebastian Harder
Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy
Philip S Wells, Martin Gebel, Martin H Prins, Bruce L Davidson, Anthonie WA Lensing
Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays
Jonathan Douxfils, Anne Tamigniau, Bernard Chatelain, Catherine Goffinet, Jean-Michel Dogné, François Mullier
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
Rupert M Bauersachs, Anthonie WA Lensing, Martin H Prins, Dagmar Kubitza, Ákos F Pap, Hervé Decousus, Jan Beyer-Westendorf, Paolo Prandoni
Paxillin is an intrinsic negative regulator of platelet activation in mice
Asuka Sakata, Tsukasa Ohmori, Satoshi Nishimura, Hidenori Suzuki, Seiji Madoiwa, Jun Mimuro, Kazuomi Kario, Yoichi Sakata
The effect of a continuing medical education program on Venous thromboembolism prophylaxis utilization and mortality in a tertiary-care hospital
Fahad Al-Hameed, Hasan M Al-Dorzi, Essam Aboelnazer
Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians
Stuart G Nicholls, Jamie C Brehaut, Rubab G Arim, Kelly Carroll, Richard Perez, Kaveh G Shojania, Jeremy M Grimshaw, Roy M Poses
Successful thrombolysis following enoxaparin therapy in two pediatric patients with congenital heart disease presenting with intracardiac and cerebral thrombosis
Gesa Wiegand, Vanya Icheva, Martin Schöning, Michael Hofbeck
Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants
Vincent Geldhof, Christophe Vandenbriele, Peter Verhamme, Thomas Vanassche